When was Orcosa founded?

Orcosa was founded in 2020 and raised its 1st funding round 1 year after it was founded.

Where is Orcosa located?

Orcosa is headquartered in Canada.

How many employees does Orcosa have?

As of Sep 30, 2026, the latest employee count at Orcosa is 12.

Is Orcosa a funded company?

Orcosa is a funded company, having raised a total of $18.6M across 2 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Sep 27, 2021.

When was the latest funding round of Orcosa?

Orcosa's latest funding was a $***** Series B round on Dec 23, 2024, with participation from 0 investor.

Where does Orcosa rank among its competitors?

Orcosa ranks 64th amongst 326 active competitors, of which 43 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Orbis Medicines, which secured an undisclosed amount in Sep, 2026.

Who are the top competitors of Orcosa?

Orcosa's top competitors include Sanity Group, Cure Pharmaceutical and Terraflos. Among them, Orbis Medicines secured the most recent funding round in September, 2026.

Orcosa - 2026 Company Profile, Funding & Competitors

Orcosa is a series B company based in Canada, founded in 2020. It operates as a Developer of cannabinoid-based therapeutics for oncology and neurological disorders. Orcosa has raised $18.6M in funding. The company has 326 active competitors, including 43 funded and 69 that have exited. Its top competitors include companies like Sanity Group, Cure Pharmaceutical and Terraflos.

Company Details

Developer of cannabinoid-based therapeutics for oncology and neurological disorders. The company has developed non-opioid analgesics based on rapid infusion technology. It targets CB1 and CB2 receptors to treat traumatic brain injury, neurodegenerative disease, and tumors.

Website: www.orcosa.com/
Email ID: *****@orcosa.com

Key Metrics

Founded Year

2020

Location

Canada

Stage

Series B

Total Funding

$18.6M in 2 rounds

Latest Funding Round

Series B, Dec 23, 2024, $*****

Ranked

64^th among 326 active competitors

Employee Count

12 as on Sep 30, 2026

Similar Companies

Sanity Group & 376 more

View Orcosa's full profile

Orcosa has raised a total funding of $18.6M over 2 rounds. Its first funding round was on Sep 27, 2021.

Here is the list of recent funding rounds of Orcosa:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 23, 2024	9056984	Series B	2231792	8611232	3537239	8994304
Sep 27, 2021	5152935	Series B	1475316	3391283	4327523	5708201

Access funding benchmarks and valuations. Sign up today!

View details of Orcosa's funding rounds and investors

Orcosa's employee count trend

Orcosa has 12 employees as of Sep 26. Here is Orcosa's employee count trend over the years:

Uncover Orcosa's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Orcosa include Sanity Group, Cure Pharmaceutical and Terraflos. Here is the list of Top 10 competitors of Orcosa, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Sanity Group 2011, Berlin (Germany), Acquired	Developer of cannabinoid-based pharmaceuticals and well-being products	$109M	HV Capital, TQ Ventures & 19 others	67/100
2nd	Cure Pharmaceutical 2010, Oxnard (United States), Public	Developer of oral thin film based drug delivery systems	$9.65M	Onbelay Capital, Hangar202 & 1 others	62/100
3rd	Terraflos 2021, Uruguay, Seed	Provider of cannabis medical products	$11.5M	Rainforest Capital, YaaX Capital & 4 others	60/100
4th	gLeaf 2014, Frederick (United States), Acquired	Medical cannabis cultivator	$19.4M	Chicago Atlantic	59/100
5th	BOHECO 2013, Mumbai (India), Seed	Provider of cannabis-derived nutritional and wellness products	$11.5M	Absolem Technologies, S R B Buildtech LLP ... & 34 others	56/100
6th	Vivtex 2018, Cambridge (United States), Seed	Developer of oral drug delivery system	$1.8M	-	56/100
7th	ZYUS Life Sciences 2018, Saskatoon (Canada), Public	Developer of cannabis-derived therapeutics for multiple indications	$19.5M	Keyhorse Capital, Mammoth View	55/100
8th	Cingulate 2012, Kansas City (United States), Public	Developer of therapeutics for the treatment of ADHD	$33M	The Werth Family Foundation, Lincoln Park Capital ... & 2 others	55/100
9th	Orbis Medicines 2022, Copenhagen (Denmark), Series A	Provider of drug discovery platform to develop multiple therapeutics	$126M	Novo Holdings, New Enterprise Associates & 5 others	54/100
10th	OnDosis 2017, Gothenburg (Sweden), Series B	Developer of an oral drug delivery system	$14.5M	Aeternum, EIC Fund & 7 others	54/100
64th	Orcosa 2020, Canada, Series B	Developer of cannabinoid-based therapeutics for oncology and neurological disorders	$18.6M	-	35/100